The effect of brefeldin-A (BFA), a reversible inhibitor of vesicular transport, on cholera toxin (CT)-induced Cl-secretion (4S,) was examined in the polarized human intestinal cell line, 
Introduction
Secretory diarrhea caused by Vibrio cholerae is induced in large part by the direct action of cholera toxin (CT)' on polarized intestinal epithelial cells ( 1) . The toxin elicits a secretory response directly by activating adenylate cyclase on the basolateral membrane of epithelial cells and indirectly by action on submucosal nerves (2) or other lamina propria cells (3) . In intestinal crypt epithelia, toxin-induced activation ofadenylate cyclase raises intracellular levels ofcAMP which elicits the pri- 1 . Abbreviations used in this paper: A,, CT-A,-peptide; AC, adenylate cyclase; ARF, ADP-ribosylating factor; BFA, brefeldin A; CT, cholera toxin; Gsa, hetertrimeric GTPase Gsa; PKA, protein kinase. mary transport event of secretory diarrhea, electrogenic C1-secretion (4) .
CT (84 kD) consists of 5 identical B-subunits (11 kD) which bind specifically to ganglioside GM, on cell membranes and a single enzymatic A-subunit (28 kD) comprised of two peptides (23 kD and 5 kD) linked by a disulfide bond (5) . In nature, the toxin binds by its B-subunits to ganglioside GM, in the apical membrane of polarized intestinal epithelia but activates adenylate cyclase (6) on the cytoplasmic surface of the basolateral membrane (7, 8) . Neither GM, nor CT can pass through intercellular tight junctions (9, 10) and the mechanism by which apically bound CT transduces a signal to basolateral adenylate cyclase (or to submucosal tissues) remains undefined.
CT-induced activation of adenylate cyclase occurs only after an unexplained "lag phase" of 10-40 min after binding to the cell surface ( 11 ) . Studies on a variety of nonpolarized cells have shown that during this lag phase, the A-subunit translocates across the plasma membrane (or possibly across the endosome membrane [12] ) to the cytoplasmic membrane surface ( 13, 14, 15) . During or after translocation, the A-subunit undergoes reductive cleavage to form the enzymatically active A,-peptide (13) . Whether the A,-peptide dissociates completely from the B-subunit or from the cell membrane after translocation remains undefined. Eventually, the A,-peptide gains access to and catalyses the ADP-ribosylation ofthe heterotrimeric G-protein, Gsa, which leads to activation ofadenylate cyclase ( 16, 17) . It is not known where in the cell translocation of the A-subunit occurs or where the A,-peptide encounters Gsa. Furthermore, in polarized epithelia, where the apical toxin binding site is separated from basolateral adenylate cyclase by circumferential tight junctions, it is not known whether the A,-peptide itself or rather ADP-ribosylated-Gsa moves to the basolateral membrane, thus linking the apical signal with the basolateral effector (7, 18, 19) . Previous studies in nonpolarized cells have shown that CT is internalized by receptor-mediated endocytosis (20, 21, 22) but whether endocytosis and vesicular traffic of toxin-containing membranes plays any role in signal transduction was not examined directly.
We have recently defined the human intestinal cell line T84
as a model to study the mechanism of CT action on polarized epithelia ( 19 Quantitation ofreduction ofA-subunit after binding ofCT to T84 cells. '25I-labeled CT was prepared as previously described (34) and had a specific activity of 200-400 cpm/fmole and a half-maximal effective dose (EDmI = 500-800 pM) identical to that of native toxin when applied to apical surfaces of T84 monolayers. Reduction of the A-subunit to the A,-peptide was assessed using modifications of methods described by Kassis (13) and LeBivic (35 SDS-lysis buffer (0.5% SDS, 20 mM Tris, 150 mM NaCl, 5 mM EDTA, 20 mM triethanolamine, 10 mM N-ethylmaleimide, I mM PMSF, and 10 Mg/ml chymostatin, pH 7.4) followed by treatment with 2.5 MM diisopropylfluorophosphate and incubation at 65°C for 5 min. The extract was then returned to 4°C and diluted 1:1 (vol/vol) with triton dilution buffer (2.5% triton-X 100, 20 mM Tris, 150 mM NaCl, 5 mM EDTA, 20 mM triethanolamine, 10 mM N-ethylmaleimide, 1% Na Azide, 1 mM PMSF, and 10 ,g/ml chymostatin, pH 7.4).
After shearing the DNA by vortex and needle aspiration, the A-subunit and A,-peptide were immunoprecipitated using 20 ,l ( 1:600 final dilution) polyclonal antiserum raised against heat and SDS-denatured CT A-subunit followed by 150 Ml protein-A sepharose. The protein-A beads were washed three times with mixed micelle buffer (1% triton-X 100, 0.2% SDS, 8% sucrose, 20 mM Tris, 150 mM NaCI, 5 mM EDTA, 20 mM Triethanolamine, 10 mM N-ethylmaleimide, 1% NaAzide, 1 mM PMSF, and 10 ,g/ml chymostatin, pH 7.4) and once with final wash buffer (8% sucrose, 20 mM Tris, 150 mM NaCl, 5 mM EDTA, 20 mM Triethanolamine, 10 mM N-ethylmaleimide, 1% NaAzide, 1 mM PMSF, and 10 ,g/ml chymostatin, pH 7.4). The pelleted beads were resuspended in 150 Ail sample buffer (4% SDS, 8 M urea, 5 mM EDTA, 10 mM NEM, 0.34 M sucrose), heated to 65°C for 5 min and repelleted. 50-80% of radioactivity contained in the final lysate was recovered. The supernatants were run on nonreducing 12% SDS-polyacrylamide gels. The gels were stained and fixed with Coomassie blue, destained, and each lane was cut into 1-mm slices. Total radioactivity in slices was quantified by gamma counting, and radioactive peaks corresponding to A-and A,-subunits were identified. The fractional component of A,-peptide was defined as the ratio ofA-to A-band integrals as previously described ( 19) .
Conventional and confocal fluorescence microscopy. Binding and internalization of CT in T84 cell monolayers were visualized using rhodamine-labeled (CT-rhodamine) and fluorescein-labeled (CT-fluorescein) toxin analogs, prepared as previously described ( 19) . CT-rhodamine was functionally active with an ED50 identical to native toxin.
CT-fluorescein did not elicit a secretory response from T84 cells but bound specifically to ganglioside GM1 as assessed by morphology. After incubation with 20 mM CT-fluorescein or CT-rhodamine at 4°C or 37°C, T84 monolayers were washed three times in HBSS at 4°C, fixed in a solution of 4% paraformaldehyde and 5% sucrose in PBS ( 150 mM NaCl, and 20 mM NaH2PO4/Na2HPO4, pH 7.4) for 30 min at 4°C, rinsed in PBS, and mounted in 1:1 PBS/glycerol containing 1% n-propyl gallate. Monolayers grown on filter supports were excised 2942 from the plastic insert, mounted in PBS/glycerol as above, and examined using a Zeiss Axiophot photomicroscope (Carl Zeiss, Oberkochen, Germany) equipped with an argon laser and Biorad MRC600 confocal imaging system (BioRad/Analytical Instruments Corp., Cambridge, MA). Monolayers grown on glass coverslips were mounted in PBS/glycerol as above or in Moviol (Hoechst AG, Basel, Switzerland) and examined using a Zeiss Axiophot photomicroscope equipped with a 546±12 nm narrow band pass excitation filter and a 590-nm-long pass barrier filter. Photographs were taken using T-Max 400 film (Eastman Kodak Co., Rochester, NY).
For immunocytochemical localization of the Golgi associated protein p200 (36) , monolayers grown on glass coverslips were incubated in HBSS with and without BFA for 30 min at 370C and fixed as described above. The fixed monolayers were permeabilized by incubation in 1% Triton X-100 in PBS for 20 min at 21'C, and then washed extensively in PBS containing 1% BSA (PBS/BSA). Mouse mAbs against the Golgi protein p200 (obtained from Dr. Brian Burke, Harvard Medical School, Boston) were diluted 1:1,000 in PBS/BSA and applied to the permeabilized monolayers. Bound antibodies were visualized by subsequent incubation with rhodamine-labeled goat antimouse IgG (Cappel Laboratories, Corp., Durham, NC). Monolayers were mounted and photographed as described above.
Preparation of T84 cell membrane and cytosolfractions. T84 cell membranes and cytosol were prepared by differential centrifugation as described by Kaoutzani (37) . Briefly, T84 cells were scraped into homogenization buffer (0.34 mM sucrose, 10 mM Hepes, 1 mM EDTA, 0.1 mM MgCl2), lysed by nitrogen bomb (200 psi for 15 min), treated with 2.5 AM diisopropylfluorophosphate, and centrifuged at 1,000 g for 20 min to remove nuclei and unbroken cells. The resulting supernatant was centrifuged at 100,000 g for 1 h to obtain a crude postnuclear cell pellet (-1.5 mg/ml protein) and supernatant (-0.2 mg/ml protein).
ADP-Ribosylation of Gsa. CT-induced ADP-ribosylation of T84 cell membranes was performed using modifications of the protocol described by Ribeirto-Neto (38) . Briefly, 20 ,gm T84 cell membranes were incubated for 3 h at 4°C with sequential 10-fold dilutions of CT (as indicated) and 300 mM KH2PO4/K2HPO4 (from 2.4 M stock prepared at pH 7.0), 12.5 mM tris-base (adjusted to pH 7.5), 10 mM thymidine, 10.5 mM MgCl2, 1 mM EDTA, 1 mM ATP, 0.1 mM GTP, 0.8% lubrol-Px, and 60MgM NAD (containing 2 ,Ci 32P-labeled NAD/ sample as tracer) in a total volume of 120 Ml. The reaction was stopped by the addition of 1 ml ice cold trichloroacetic acid followed by centrifugation at 14,000 g for 15 min. The pellets were washed in 1 ml ice cold ether, centrifuged again, and resuspended in 30 ,l SDS-sample buffer.
Membrane proteins were resolved by SDS-PAGE and autoradiographed.
Statistics. BFA effects on CT-induced Cl -secretion and formation ofA,-peptide were analyzed by t test and ANOVA using Statview 512+ software (Brainpower, Inc., Calabasas, CA).
Results
Cholera toxin-induced Cl-secretion is inhibited reversibly by brefeldin A. Pretreatment of T84 monolayers with 5 MiM BFA at 37°C 10 min before the addition ofCT ( 120 nM) completely inhibited the secretory response to CT applied either to apical or basolateral cell surfaces (peak I4, for apical CT: 2.4±0.5 vs. 68±3 MA/cm2; peak I4 for basolateral CT: 2.9±0.5 vs. 74±3 ,A/cm2, mean±SEM, n = 5, P = 0.0001 respectively) (see Fig.   1 A). In contrast, BFA had no effect on the secretory response to the cAMP agonists 1 nM vasoactive intestinal peptide (VIP), 1 MM forskolin, or 3 mM 8Br-cAMP ( Fig. 1 B) . The time course of toxin-induced Cl-secretion (0.5 nM CT) in the presence and absence of BFA (5 MM) and after BFA removal is shown in Fig. 2 . Monolayers exposed to apical CT in the absence of BFA elicited a strong secretory response after a 45±2 min lag phase (peak I4 = 22±1.8 MA/cm2, mean±SEM, n = 6). In contrast, toxin-induced Cl -secretion was completely inhibited in those monolayers pretreated with BFA (apical CT: I4 = 1.7±0.3 ,uA/cm2, mean±SEM, n = 4; basolateral CT: I4, = 2.5±0.5 MA/cm2, n = 6). Removing BFA by exchanging reservoir buffers at 100 min ("wash" arrow, Fig. 2 ) permitted recovery of toxin induced Cl-secretion after an additional 88±3 min for apical CT (peak I4C = 10.9±0.3 MuA/cm2, mean±SEM, n = 4) and 70±3 min for basolateral CT (peak I4, = 19±1.1 uA/cm2; n = 6). In contrast, exchanging reservoir buffers had no effect on I4, in control monolayers not exposed to CT whether treated or not treated with BFA ( 1.3±0.2 and 1.4±0.4 MA/cm2, mean±SEM, n = 2). The viability of these FBI [E Toxin-induced signal transduction and cell polarity. We next examined the time and dose dependency of BFA action. To determine when the rate-limiting BFA-sensitive event occurred in the complex sequence of events leading to toxin-induced C1-secretion (Fig. 3 ), monolayers were incubated with CT at 4VC for 30 min (to allow steady-state binding to cell surfaces) and then shifted to 370C, which defined the beginning ofthe lag phase. The monolayers were then either treated with BFA (5 ,M) at the onset ofthe lag phase (at time 0 min), at sequential points throughout the lag phase (at 1, 2.5, 5, 10, etc., min), or not treated with BFA. When cholera toxin was applied to apical cell surfaces, BFA completely inhibited toxin induced Cl-secretion only if it were added within the first 10 min of the lag phase (Fig. 3, hatched bars) . In monolayers exposed to basolateral toxin, however, BFA did not completely inhibit a secretory response unless applied within the first minute (Fig. 3, solid bars) . Thus, the entire fraction ofapical toxin remained in a BFA-sensitive compartment(s) for at least 5 min while a small fraction of basolateral CT had already moved beyond a BFA-sensitive step within 1 min after the monolayers were shifted to permissive temperatures. Apparent half-times for transit through the BFA-sensitive compartment(s) were 20 min from the apical membrane and 10 min from the basolateral membrane (n = 4, two-tailed t-test, P = 0.001 ).
The importance of cell polarity in toxin-induced signal transduction was further emphasized by small but reproducible differences in the dose dependency of BFA inhibition (Fig. 4) . The Cl-secretory response in monolayers exposed to apical CT were twofold more sensitive to BFA than in monolayers exposed to basolateral CT (ED50 = 55 vs. 90 nM, mean, n = 2). Taken together, these studies show that the cellular processing of both apical and basolateral CT was sensitive to BFA if applied early in the lag phase, and that the mechanism of toxin action from the apical cell surface involved additional (or different) steps that were more sensitive to BFA and longer in duration. Mechanism of CT action: identification of the BFA-sensitive event. For CT to act directly from either the apical or basolateral membrane, the toxin must first bind specifically to ganglioside GM, on the cell surface, the A-subunit must translocate across the membrane and undergo reductive cleavage to form the enzymatically active A,-peptide, and the Al-peptide must eventually catalyze the ADP-ribosylation ofthe heterotrimeric GTPase, Gsa, which activates adenylate cyclase. These events are measurable landmarks that can serve to delineate potential sites of BFA-sensitivity.
To examine the possible effect ofBFA on CT binding to cell surfaces, the fluorescent toxin analog CT-fluorescein (10 nM) was applied to apical or basolateral reservoirs of T84 monolayers and visualized by laser confocal microscopy. When applied to apical reservoirs at 40C in the presence ofBFA (5 MM), a bright fluorescent signal was apparent at apical cell surfaces (Fig. 5 A) . Fluorescence was not detected either within T84 cells or on the contralateral cell surface, indicating both that endocytosis was effectively inhibited at 40C and little, if any, CT-fluorescein passed through tight junctions by a paracellular route. Similarly, when applied to basolateral reservoirs at 40C in the presence of BFA, CT-fluorescein outlined basolateral cell surfaces with no detectable signal within the cell or at the apical membrane (Fig. 5 B) . The fluorescent signals were completely inhibited by co-incubation with 100-fold excess unlabeled (nonfluorescent) CT indicating that the binding was specific and receptor mediated. These data show that BFA did not inhibit the specific binding of CT-fluorescein to either apical or basolateral plasma membranes.
A possible direct effect of BFA on CT-catalyzed ribosylation ofGs a was examined in crude T84 cell membrane preparations (100,000 g postnuclear cell pellets) incubated in vitro with serial 10-fold dilutions of CT (10-6 to 101-2 M) and 2 tCi 32P-labeled NAD in the presence or absence of 1 mM BFA (> 104-fold excess over IC50 for intact cells). Membrane proteins were separated by SDS-PAGE and autoradiographed (Fig. 6) . CT preferentially catalyzed the ADP-ribosylation of two membrane proteins with apparent mol mass of 45 and 52 kD (arrowheads), both of which were immunoreactive with antibodies against Gsa as assessed by western blot (data not shown). The CT-catalyzed ADP-ribosylation of these protein bands displayed an identical dose dependency in the presence or absence of BFA over three orders of magnitude ( 10-6_ 10-8) . These data indicate that in membrane fractions, where spatial restrictions on the ability of CT to interact with its substrate are not rate limiting, BFA had no effect on the ability of CT to ADP-ribosylate Gsa.
To examine the possibility that BFA might affect reductive cleavage and presumably translocation (13) of the A-subunit by intact T84 cells, we assessed the degree of reduction of CT to the A,-peptide after application of the toxin to apical cell surfaces in the presence or absence of BFA (5 ,uM). '251-labeled CT (20-40 nM) was applied to the apical surfaces of T84 monolayers at 4°C for 30 min. Monolayers were then either warmed to 37°C for 60 min in the presence or absence of BFA or kept at 4°C to define background levels of A-subunit reduction. Reduction of the A-subunit was detected by the appearance of radiolabeled A,-peptide that is shifted in electrophoretic mobility on non-reducing polyacrylamide gels. Fig. 7 summarizes the results (mean±SEM, n = 3) of these experiments. After 1 h at 37°C, T84 monolayers not treated with BFA produced nearly twofold more A,-peptide (12±1.4%) than control monolayers kept at 4°C (6.4±0.6%) (ANOVA, P < 0.007). In contrast, the fraction of Al-peptide produced by monolayers incubated at 37°C in the presence of BFA (6.5±0.3%) was no different than that seen in 4°C controls.
To determine if BFA directly inhibited reduction of the A-subunit in vitro, CT (1 mg/ml) was mixed (1:20 vol/vol) Endocytosis ofCT-containing membranes and Golgi structure in the presence of BFA. We have previously shown that toxin-induced signal transduction from the apical membrane of T84 cells requires entry of CT into the apical endosomal compartment ( 19) . To examine whether BFA inhibited toxin action by affecting endocytosis of toxin-containing membranes, the functional fluorescent-toxin analog CT-rhodamine was visualized directly within T84 cells by conventional epifluorescence microscopy. T84 monolayers grown on glass coverslips were incubated with CT-rhodamine (20 nM) at 40 or 37°C for 40 min in the presence (or absence) of BFA. At 4°C, CT-rhodamine was visualized in a pattern consistent with toxin binding to apical cell surfaces (Fig. 8 A) . Competition with 50-fold excess nonfluorescent CT (1O min preincubation followed by 40 min co-incubation with CT-rhodamine at 4°C) reduced the fluorescent signal below detectable levels (data not shown) indicating that binding was specific (Fig. 8 B) . When monolayers were incubated at 37°C (for 40 min) in the presence of BFA, CT-rhodamine was visualized within intracellular structures of nearly all cells in a pattern consistent with endocytic uptake (Fig. 8 C) . Competition with 100-fold excess nonfluorescent-CT (10 min preincubation followed by continuous 40-min co-incubation with CT-rhodamine at 37°C) completely eliminated the labeling of intracellular structures (Fig. 8  D) , confirming that internalization in BFA-treated cells was also receptor mediated. Thus BFA did not affect endocytosis of CT-containing membranes.
To determine whether Golgi structure in T84 cells was sensitive to BFA, we examined whether treatment with BFA caused a redistribution of the Golgi associated protein p200 as assessed by immunocytochemistry. Dissociation of p200 from 2946 Lencer, de Almeida, Moe, Stow, Ausiello, and Madara Golgi membranes occurs rapidly upon exposure to BFA and precedes gross disruption ofGolgi morphology (36) . We found that in T84 cells not treated with BFA mAbs against p200 labeled perinuclear structures consistent with the location of Golgi stacks (data not shown). These structures were not labeled in monolayers treated with BFA for 45 min before fixation (ED50 -100 nM) or in control monolayers that were fixed but not permeabilized before incubation with antibodies against p200. Taken together, these data indicate that Golgi structure, as assessed by localization of the coat protein p200, was sensitive to BFA, but endocytosis of CT-containing membranes from the cell surface was not.
Two sequential and distinct events involving vesicular transport are required for signal transduction from the apical cell surface. We ature-sensitive step that was not necessary for the action of basolateral CT. This temperature-sensitive event occurred late in the lag phase after formation of the Al-peptide ( 19) . In contrast, the rate limiting BFA-sensitive event described in this study occurred early in the lag phase before formation of the A1-peptide. To distinguish more clearly between these events, we examined the time course ofCT-induced Cl -secretion after shifting monolayers to nonpermissive temperatures late in the lag phase in the presence or absence of BFA (5 MM) (Fig. 9 ).
T84 monolayers exposed initially to apical or basolateral CT at 40C, were preincubated at 370C for 27.5 min to allow endocytosis and A-subunit translocation and returned to nonpermissive temperatures ( 13 -15°C). Those monolayers exposed to apical CT were either treated with BFA late (at 27.5 min, after preincubation at 37°C) or early (at 0 min, before preincubation at 37°C) in the lag phase. Control monolayers exposed to apical CT were not treated with BFA. As previously reported, after shifting monolayers to nonpermissive temperatures, basolateral CT induced a Cl -secretory response (dI.Ijdt = 0.03±0.01 ,AA/cm2/min; peak IS, = 7.9±0.6 MA/cm2, mean±SEM, n = 7) but the action of apical CT (in the presence or absence of BFA) was completely inhibited even after 325 min (dIljdt = not present; peak I. = 0.6 to l.0 MA/cm2). In monolayers treated with apical CT, rewarming to 32°C (at 325 min) restored toxin-induced Clsecretion in those monolayers not treated with BFA (dIs,/dt = 0.09±0.007; peak I_ = 14+2 MA/cm2, n = 7) and in those monolayers treated with BFA late in the lag phase though the peak response was attenuated by the addition of BFA at 27.5 min (dI4c/dt = 0.09±0.04; peak I4 = 8±2 MA/cm2, n = 7). In contrast, rewarming did not restore Cl-secretion in monolayers treated with BFA early in the lag phase (dI4/dt = not present; peak I4, = 1.0±0.3 MAA/cm2, n =7) or in control monolayers not exposed to CT (dIs,/dt = not present; peak I4 = 0.9±0.2 MA/cm2, n = 7). The viability of these nonsecreting monolayers was demonstrated by the brisk secretory response elicited by VIP at 400 min (dIsc/dt = 11±4.6 MAA/cm2/min; peak ISC = 20± 1.5 MA /cm2). Table I summarizes the results of these experiments. In the absence of a temperature block, monolayers treated with BFA late in the lag phase would normally respond to apical CT with a strong secretory response (see Fig. 3 ). However, when monolayers were also shifted to nonpermissive temperatures late in the lag phase at the time ofBFA treatment (at 27.5 min) toxininduced Cl-secretion was completely inhibited. The data show that two sequential and distinct events, comprised of an early lag phase BFA-sensitive event followed by a late lag phase temperature-sensitive event, are essential for toxin-induced signal transduction from the apical membrane. This was demonstrated directly by rewarming to permissive temperatures at 325 min, which released the temperature block and elicited a toxin-induced secretory response in those monolayers treated with BFA late in the lag phase (at 27.5 min) but not in those monolayers treated with BFA early in the lag phase (at 0 min).
Discussion
In this report, using the fungal metabolite BFA, we identify an event involving vesicular transport that is required for a biologic response to apical CT and that is distinct from the late lag phase temperature-sensitive vesicular transport event previously described ( 19) . The BFA-sensitive event occurs early in the lag phase and involves the transport of CT to a site beyond the early endosome where the A-subunit is reduced to the A,-peptide. The data strongly suggest that in polarized epithelia, vesicular transport through multiple compartments of membranes containing CT (and possibly also ADP-ribose-Gsa) play an essential role in the mechanism oftoxin-induced signal transduction.
Brefeldin A as a probe ofvesicular transport in the mechanism of CT action. Brefeldin A has structural and functional effects on the endoplasmic reticulum, the Golgi complex, the endosomal system and the trans-Golgi network of a variety of cell types (23, 24, 25, 40, 41) . The drug appears to act by interfering with the regulated assembly of specific cytosolic coat proteins required for the budding and transport of vesicular carriers associated with these organelles (27, 42, 43, 44, 45) . As a result, BFA disrupts the steady-state distribution of membranes and membrane components, and organelle identity and function are altered. At the cellular level, disruption of vesicular transport by BFA has been shown to strongly inhibit protein secretion from hepatocytes (46) and MDCK cells (47); antigen presentation by MHC class-I and -II molecules on B-cell hybridomas (48, 49); ganglioside biosynthesis in primary cultured cerebellar cells (50); cytotoxicity of ricin, modeccin, and Pseudomonas toxins in CHO, Vero, and NRK cells (5 1 ); and transcytosis of the polymeric immunoglobulin receptor in MDCK cells (25) . In many of these cell systems, however, endocytosis and rapid recycling of specific membrane components to the cell surface were not affected (24, 25, 46, 51) . We found that T84 cells are also sensitive to BFA since, like in many of the systems described above, Golgi structure was perturbed by the drug as assessed by the redistribution of the Golgi-specific coat protein p200 (36) .
In this report, we show that brefeldin A completely and reversibly inhibited CT-induced Cl -secretion in the epithelial cell line T84. In contrast, BFA did not inhibit Cl-secretion induced by other agonists, which activated Gsa via a basolateral cell surface peptide receptor or which directly activated A-kinase or adenylate cyclase. Not only was inhibition of the Cl-secretory response by BFA specific for CT, but this inhibition was only manifested on intact cells. For example, BFA did not inhibit the reduction ofthe CT A-subunit to the enzymatically active Al-peptide when CT and extracted cytosol were coincubated in the presence of this drug. Furthermore, BFA did not inhibit the Al-peptide catalyzed ADP-ribosylation of Gsa in membrane fractions ofT84 cells. The data indicate that CT action on intact T84 cells requires BFA-sensitive steps unique from other cAMP-mediated secretagogues, and that BFA does not block CT action by interfering with the toxin's ADP-ribosyltransferase activity.
Effect of epithelial cell polarity on the mechanism of CT action. We have previously shown that the time course and temperature-sensitivity of the secretory response to apical CT in T84 cell monolayers was different from that ofCT applied to basolateral membranes ofthe same cells ( 19) . In this report, we show that the secretory response elicited by apical CT also differed in sensitivity to BFA. Our data indicate that BFA acts at an early stage in the lag phase for both apical and basolateral CT and suggest that signal transduction by basolateral CT may also involve endocytosis and vesicular transport of CT-containing membranes. These data are consistent with studies reported while this manuscript was under review, that BFA effects CT action on nonpolarized cells (29, 30) . In the polarized T84 cell model, however, we find that the half-time for transit through a BFA-sensitive compartment was significantly longer for CT bound to apical cell surfaces. In addition, we found that the secretory response elicited by apical CT was almost twofold more sensitive to BFA than the secretory response elicited by basolateral CT. These differences in time and dose dependency suggest that BFA may inhibit CT-induced Cl-secretion by acting at similar but not necessarily identical site(s) in the apical and basolateral endocytic pathways. Indeed, available evidence from a variety of other cell systems indicate that BFA may have specific effects at multiple sites within the central vacuolar system of a single cell type (25, 28, 52, 53) . Taken together, our studies suggest that the mechanism of toxin action from the apical (or physiologic) cell surface entails additional steps (temperature-sensitivity late in the lag phase), steps of longer duration, and steps with differing sensitivity to BFA than that required from the basolateral cell surface. Since CT action has previously been examined in nonpolarized cell systems, these observations also suggest that the pathway of signal transduction seen in nature may entail complexities not previously appreciated.
Mechanism of BFA-action at the membrane surface: the role ofADP-ribosylatingfactors in CT-induced signal transduction. The mechanism ofBFA-action has been most extensively studied by examining the drug's effect on Golgi membranes (27, 42, 43-45, 54-56 ). These studies show that brefeldin A may act by interfering with the GTP-dependent assembly of specific coat proteins required for the budding and transport of vesicular carriers between Golgi stacks. The data indicate that a family of small molecular weight GTP-binding proteins, termed ADP-Ribosylating Factors (ARF), play a fundamental role in GTP-dependent coat assembly (57) (58) (59) (60) . GDP/GTP exchange redistributes ARF between membrane-associated and cytosolic forms (61, 62) . Movement of ARF onto Golgi membranes appears to be a prerequisite for the assembly of coat proteins on nascent transport vesicles (57) , and recent evidence, from two independent laboratories, indicate that this process may be catalyzed by a BFA-sensitive Golgi membrane associated GDP/GTP exchange factor (63, 64) .
It is not known whether BFA interferes with vesicular transport between other organelles by acting on ARF or related exchange factors located at different sites within the endocytic and exocytic pathways. However, convincing data now indicate that ARF proteins are required for vesicular traffic in Saccharomyces cerevisiae (59) and play an important role in regulating vesicular traffic between ER and Golgi (65), within the endosomal compartment (66) , as well as between Golgi cisternae (67) in mammalian cells. These studies raise the possibility that ARF may play a role in the BFA-sensitive event required for transport of CT beyond the early apical endosomal compartment in T84 cells. If so, this would be particularly relevant because the ARF protein family was initially identified based on the ability of ARF to act as potent allosteric activators of CT actions in vitro (68) . One might even speculate that CT has evolved to facilitate its own movement through the endocytic pathway by interacting with ARF. In our in vitro assay oftoxin ADP-ribosyl-transferase activity, we found that CT catalyzed the ADP-ribosylation a 20-kD protein present in T84 cell membrane pellets (Fig. 7, * at 20 kD) . Since CT is known to ADP-ribosylate ARF in vitro (69), we sought to determine the identity of this 20-kD membrane protein. However, although this protein had an identical electrophoretic mobility on SDS-PAGE to cytosolic ARF it was not clearly immunoreactive with polyclonal antibodies against ARF as assessed by western blot (data not shown; antibodies obtained from Dr. Joel Moss, National Institutes of Health, Bethesda, MD).
Sequential BFA-and temperature-sensitive events are requiredfor signal transductionfrom the apical membrane. These studies have functionally identified two sequential events required for a biologic response to apical CT (Fig. 10) . Both events occur after binding to apical cell surfaces and after entry into an apical endocytic compartment. The first event occurs early in the lag phase and involves BFA-sensitive transport of CT to an intracellular compartment where reduction of the A-subunit (and possibly translocation) occurs. The second event occurs late in the lag phase and involves temperaturesensitive signal transduction (presumably via the A,-peptide but possibly via ADP-ribose-Gsa) to the basolateral domain. This late lag phase temperature-sensitive event was apparent only when CT was applied to apical (physiologic) cell surfaces (19) .
Though the exact intracellular compartments associated with these events are not yet known, the data strongly support a role for multi-compartmental vesicular traffic in the mechanism of toxin action. Based on our current understanding, we propose the following working model. CT-induced signal transduction from apical membranes of polarized T84 cells requires toxin entry into the early apical endosomal compart- (71 ) . Signal transduction to adenylate cyclase on the basolateral membrane may then be mediated by movement of ADP-ribose-Gs a, the toxin-Gs a complex, or both.
Since CT has an apical membrane receptor (ganglioside GM,) but a basolateral effector (adenylate cyclase), signal transduction by apically bound CT may represent a paradigm for the study of targeted protein movement through polarized epithelia. If so, elucidating the molecular mechanisms specific to the endocytosis and transport of CT-containing membranes may lead to further clarification of these fundamental aspects of epithelial cell biology.
